Type Public (LSE: DPH) Operating income Website www.dechra.com Revenue 203.5 million GBP (2015) | Industry Pharmaceuticals Net income £19.5 million (2015) Headquarters Northwich, United Kingdom Founded 1997 | |
Key people Michael Redmond, (Chairman)
Ian Page, (CEO) Stock price DPH (LON) 1,671.89 GBX -26.11 (-1.54%)3 Mar, 5:53 PM GMT - Disclaimer Subsidiaries Genitrix Ltd., Dechra Veterinary Products EU | ||
Dechra Pharmaceuticals PLC is an English-based manufacturer of veterinary products. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Contents
History
The Company was founded in 1997 by way of a management buy-out from Lloyds Chemists. It was first listed on the London Stock Exchange in 2000. In 2007 it bought VetXX, a Danish veterinary products business, for £62m. It sold its veterinary services business to US-firm, Patterson Companies, for £87.5m in July 2013 in order to focus on its higher margin manufacturing business.
Operations
The Company sells pharmaceuticals - mainly for dogs, cats, equine and food producing animals; products include Vetoryl for Cushing's disease in dogs and Felimazole for hyperthyroidism in cats. It is organised into two divisions: European Pharmaceuticals and US Pharmaceuticals.